References
Rao JM, Arulappu R. Drug use in pregnancy. How to avoid problems. Drugs 1981; 22: 409–14
Condie AP, Brumfitt W, Reeves DS, et al. The effects of bacteriuria in pregnancy on foetal health. In: Brumfitt W, Asscher AW, editors. Urinary tract infection. London: Oxford University Press, 1973
Robbie MO, Sweet RL. Metronidazole use in obstetrics and gynecology: a review. Am J Obstet Gynecol 1983; 145: 865–81
Kato T, Kitagawa S. Production of congenital abnormalities in the fetuses of rats and mice with various sulphonamides. Congenit Abnormal 1973; 13: 7–15
The Birmingham Research Unit of the Royal College of General Practitioners. Morbidity and drugs in pregnancy. J R Coll Gen Pract 1975; 25: 631–45
Gruneberg RN. Changes in urinary pathogens and their antibiotic sensitivities, 1971-1992. J Antimicrob Chemother 1994; 33Suppl. A: 1–8
Manka W, Solowiow R, Okrzeja D. Assessment of infant development during an 18-month follow-up after treatment of infections in pregnant women with cefuroxime axetil. Drug Saf 2000; 22: 83–8
Samren EB, van Duijn CM, Koch S, et al. Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia 1997; 38: 981–90
Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 1971; 284: 878–81
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Weller, T.M., Rees, E.N. Antibacterial Use in Pregnancy. Drug-Safety 22, 335–338 (2000). https://doi.org/10.2165/00002018-200022050-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-200022050-00001